Northwest Biotherapeutics Inc.

12/26/2024 | Press release | Distributed by Public on 12/26/2024 08:45

Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for Up to $50 Million Additional Financing